SCHEMBL19734489

SCHEMBL19734489

CC(C)(C)OC(=O)N1CC([C@H](O)c2cc(F)cc(F)c2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.42
MAP3K14 Q99558 2/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
USP30 Q70CQ3 1/20 0.40
PDE4B Q07343 1/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
THRB P10828 1/20 0.40
NR1H2 P55055 1/20 0.40
RORC P51449 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
IDO1 P14902 1/20 0.39
EED O75530 1/20 0.38
RBBP4 Q09028 1/20 0.38
SUZ12 Q15022 1/20 0.38
EZH2 Q15910 1/20 0.38
AEBP2 Q6ZN18 1/20 0.38
MMP13 P45452 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20164106 1.00 DPP4 (0.42) DPP4MAP3K14HDAC1HDAC2USP30
SCHEMBL19734488 1.00 DPP4 (0.42) DPP4MAP3K14HDAC1HDAC2USP30
SCHEMBL18249614 0.90 MAP3K14 (0.39) DPP4MAP3K14HDAC1HDAC2USP30
SCHEMBL18249658 0.88 DPP4 (0.44) DPP4MAP3K14HDAC1HDAC2USP30
SCHEMBL23211978 0.86 HDAC1 (0.46) DPP4HDAC1HDAC2USP30PDE4B
SCHEMBL19734532 0.86 DPP4 (0.42) DPP4HDAC1HDAC2USP30MAPT
SCHEMBL21384664 0.86 HDAC1 (0.46) DPP4HDAC1HDAC2USP30PDE4B
SCHEMBL18249566 0.86 DPP4 (0.42) DPP4HDAC1HDAC2USP30PDE4B
SCHEMBL18249668 0.85 DPP4 (0.44) DPP4MAP3K14HDAC1HDAC2USP30
SCHEMBL1529076 0.85 DPP4 (0.41) DPP4MAP3K14HDAC1HDAC2USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017216280-A1 TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-12-21 WO disclosed